Tilray stock pops on new Trump-driven cannabis hopes. Should you chase the rally?
Tilray Brands (TLRY) stock closed meaningfully higher on Monday after President Donald Trump urged the DOJ, during an Oval Office event, to expeditiously reclassify cannabis as a Schedule III drug. As …
4 Red Flags Every Cannabis Investor Should Spot
Cannabis stocks can hide serious risks, from weak finances to regulatory threats, and spotting these red flags early can help investors avoid costly mistakes.
Is Aurora Cannabis (ACB) One of Best Tobacco and Cigarette Stocks to Look at
Aurora Cannabis Inc. (NASDAQ:ACB) is one of the 10 best tobacco and cigarette stocks to invest in. As of April 15 closing, broader consensus sentiment around Aurora Cannabis Inc. (NASDAQ:ACB) was …
SNDL Inc. (SNDL) is One Cannabis Stock Investors Should Not Ignore
As of April 15 closing, consensus sentiment around SNDL Inc. (NASDAQ:SNDL) was moderately bullish. The stock received 2 Buy ratings and carries a median 1-year target price of $4.75.
Here’s why the Tilray Brands stock may surge soon despite major risks
Setup: falling wedge + small inverted H&S with price below key support ($7) and far under 50/100-day EMAs; earnings show record revenue ($206.7M), double-digit growth, improving margins (wellness …
CBD Stocks Creating Opportunities – Established (BCCI), (STG), (WEED), (ACRGF), (RLTR), (CBMJ), and Newcomer (VAPR) Lead the Charge
You would have to be living in isolation to have not picked up on the hottest marijuana derivative consumable and therapeutic center isolate CBD. CBD “Cannabidiol” is the non-psychoactive full spectrum derivative of the hemp and marijuana plant largely credited for the majority of the medical beneficial attributes associated with marijuana.
Canadian Cannabis Stocks Jump on Report U.S. May Move to Reclassify Marijuana
Canadian cannabis companies surged Wednesday after an Axios report said that the Trump Administration could move to reclassify marijuana.
US set to move to reclassify marijuana as early as Wednesday, Axios reports
WASHINGTON, April 22 (Reuters) – The United States administration is expected to move to reclassify marijuana as soon as Wednesday, Axios reported, citing an official familiar with the matter, sending U.S. stocks of cannabis-related companies higher.
Tilray stock pops on new Trump-driven cannabis hopes. Should you chase the rally?
Tilray Brands (TLRY) stock closed meaningfully higher on Monday after President Donald Trump urged the DOJ, during an Oval Office event, to expeditiously reclassify cannabis as a Schedule III drug. As …
4 Red Flags Every Cannabis Investor Should Spot
Cannabis stocks can hide serious risks, from weak finances to regulatory threats, and spotting these red flags early can help investors avoid costly mistakes.
Why The Story Around Trulieve Cannabis (CNSX:TRUL) Is Shifting With New Valuation Assumptions
Trulieve Cannabis is back in focus after an updated fair value estimate edges from CA$19.53 to CA$20.36, a measured reset rather than a sweeping overhaul. That shift lines up with broader Street …
Assessing Trulieve Cannabis (CNSX:TRUL) Valuation After New Dabstract Partnership And Recent Share Price Moves
Why the Dabstract partnership matters for Trulieve Cannabis The latest move driving attention to Trulieve Cannabis (CNSX:TRUL) is its new partnership with concentrate brand Dabstract to bring High …
NewLake Capital Partners: Collect A Double-Digit Yield From This Cannabis Landlord
NewLake Capital Partners (NLCP) offers a near-12% yield with strong occupancy, low debt and rising dividends—an overlooked cannabis REIT.
Canadians could claim part of $8-million cannabis settlement
Canadians who invested in cannabis stock could cash in on a hefty class-action settlement against Wayland Group Corp.
Cannabis stocks on track for best week of 2026 as FDA loosens CBD enforcement
Tilray Brands, Canopy Growth, and Curaleaf Holdings stocks are surging after the FDA says it won’t enforce some regulations for CBD products.
Recent Comments